<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="/prwebFeeds.xsl"?>
<rss version="2.0">
  <channel>
    <title>PRWeb.com Press Release Feed - Vocus Press Release Account Feed</title>
    <link>http://www.prweb.com</link>
    <description>PRWeb.com Press Release Feed - Press Releases</description>
    <language>en</language>
    
    <managingEditor>xml@emediawire.com</managingEditor>
    <webMaster>xml@emediawire.com</webMaster>
    <ttl>30</ttl>

<item>
    <title>Hissey Kientz to Hold Testing Sessions for Victims of Asbestos Exposure</title>
    <link>http://www.prweb.com/releases/mesothelioma-lawsuit/asbestos-testing/prweb3451564.htm</link>
    <description>
        <![CDATA[  <P>The law firm of Hissey Kientz, LLP is conducting two asbestos testing sessions in the El Paso, Texas area for individuals who may have developed cancers such as mesothelioma (http://www.hkllp.com/mesothelioma-and-asbestos/) or other diseases as a result of asbestos exposure. Testing will be take place on Saturday, January 16 and Sunday, January 17, 2010. The firm is also scheduling testing sessions in Baytown and Bay City, TX to be held in February 2010. For those who are unable to attend the scheduled testing sessions in El Paso or at another location, Hissey Kientz will issue a voucher that can be redeemed at for asbestos testing at a medical clinic near you. (PRWeb Jan 15, 2010)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/mesothelioma-lawsuit/asbestos-testing/prweb3451564.htm">http://www.prweb.com/releases/mesothelioma-lawsuit/asbestos-testing/prweb3451564.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/mesothelioma-lawsuit/asbestos-testing/prweb3451564.htm</guid>
</item>

<item>
    <title>Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN</title>
    <link>http://www.prweb.com/releases/yaz-and-yasmin/side-effects-lawsuit/prweb3320084.htm</link>
    <description>
        <![CDATA[  <P>The law firm of Hissey Kientz, LLP (http://www.hkllp.com/) is warning all women using the birth control pills Yaz or Yasmin that they may face an increased risk of blood clots, heart attack, stroke, pulmonary embolism, deep vein thrombosis and other significant side effects as a result of the defective design of these products. In addition, one of the hormones in Yaz and Yasmin (http://www.hkllp.com/yaz-and-yasmin/)&#8212;known as drospirenone, or DRSP&#8212;has been linked to an increased risk of kidney injury or gallbladder problems. (PRWeb Dec 10, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/yaz-and-yasmin/side-effects-lawsuit/prweb3320084.htm">http://www.prweb.com/releases/yaz-and-yasmin/side-effects-lawsuit/prweb3320084.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/yaz-and-yasmin/side-effects-lawsuit/prweb3320084.htm</guid>
</item>

<item>
    <title>Hormone Therapy Victims Win Important Appeal</title>
    <link>http://www.prweb.com/releases/hormone-therapy/hrt-lawsuit/prweb3188274.htm</link>
    <description>
        <![CDATA[  <P>On November 2, 2009, the United States Court of Appeals for the Eighth Circuit issued its long-awaited decision in Scroggin v. Wyeth (Case No. 08-2555). The decision gives the green light for federal trials on Wyeth&#8217;s and Pfizer&#8217;s hormone therapy (http://www.hkllp.com/hormone-replacement-therapy/) drugs. In affirming judgment on a jury verdict of compensatory damages, the federal appellate court rejected the defendants&#8217; claims that plaintiffs like Donna Scroggin cannot prove that hormone therapy caused their breast cancer. Erik Walker of Hissey Kientz, LLP (http://www.hkllp.com/) in Austin, Texas handled the appeal for Ms. Scroggin, writing her briefs and arguing to the court. (PRWeb Nov 11, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/hormone-therapy/hrt-lawsuit/prweb3188274.htm">http://www.prweb.com/releases/hormone-therapy/hrt-lawsuit/prweb3188274.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/hormone-therapy/hrt-lawsuit/prweb3188274.htm</guid>
</item>

<item>
    <title>United States Navy And Merchant Marine Veterans May Face Risk Of Mesothelioma Or Other Asbestos Diseases</title>
    <link>http://www.prweb.com/releases/navy_veterans/asbestos_exposure/prweb3118834.htm</link>
    <description>
        <![CDATA[  <P>The law firm of Hissey Kientz, LLP (http://www.hkllp.com/) wishes to alert veterans of the United States Navy or Merchant Marine that they may be at risk of developing mesothelioma or other diseases as a result of asbestos exposure suffered during their time in the military. Until the mid-1970s, many vessels used by the United States Navy (http://www.hkllp.com/mesothelioma-and-asbestos/us-navy-asbestos-exposure/) or Merchant Marine were outfitted with parts or equipment containing asbestos. As a result, veterans who served in the United States Navy or Merchant Marine during World War II, the Korean War or the Vietnam War may have been put at risk of developing asbestosis, lung cancer, mesothelioma or other diseases linked to asbestos exposure. (PRWeb Oct 28, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/navy_veterans/asbestos_exposure/prweb3118834.htm">http://www.prweb.com/releases/navy_veterans/asbestos_exposure/prweb3118834.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/navy_veterans/asbestos_exposure/prweb3118834.htm</guid>
</item>

<item>
    <title>Hissey Kientz LLP Urges Patients To Heed FDA Warning About Phospho-soda Products</title>
    <link>http://www.prweb.com/releases/fleet-phospho-soda/recall-warning/prweb2837314.htm</link>
    <description>
        <![CDATA[  <P>The law firm of Hissey Kientz, LLP (http://www.hkllp.com/) is warning consumers to immediately stop using Fleet Phospho-soda (http://www.hkllp.com/fleet-phospho-soda/) products for any purpose, including bowel cleansing prior to a colonoscopy. In December 2008 the Food and Drug Administration warned that Phospho-soda products could cause irreversible damage to the kidneys. &quot;Despite the FDA&#8217;s warnings about the dangers of Phospho-soda and Fleet&#8217;s recall of these products, some colonoscopy patients are still being advised to take Phospho-soda for bowel cleansing,&quot; says attorney David Friend of Hissey Kientz. &quot;Not only does this place patients at risk of kidney damage, but it directly contradicts the FDA&#8217;s warning about the safety of these products.&quot; (PRWeb Sep 5, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/fleet-phospho-soda/recall-warning/prweb2837314.htm">http://www.prweb.com/releases/fleet-phospho-soda/recall-warning/prweb2837314.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/fleet-phospho-soda/recall-warning/prweb2837314.htm</guid>
</item>

<item>
    <title>Minnesota Supreme Court Confirms that Minnesota&#8217;s Statutes of Limitations Govern Out-of-State Claims</title>
    <link>http://www.prweb.com/releases/hormone-therapy-lawsuit/minnesota-supreme-court/prweb2837374.htm</link>
    <description>
        <![CDATA[  <P>On September 2, 2009, the Minnesota Supreme Court held that Minnesota&#8217;s statute of limitations would govern all personal injury claims properly brought in Minnesota courts. In Fleeger v. Wyeth (A08-2124), the federal district court in Little Rock, Arkansas presiding over the hormone therapy (http://www.hkllp.com/hormone-replacement-therapy/) MDL proceedings certified a question to the Minnesota Supreme Court as to whether Minnesota&#8217;s statutes of limitations would govern the claims of out-of-state plaintiffs who sued out-of-state defendants for claims that accrued elsewhere. Erik Walker, an attorney at Hissey Kientz, LLP (http://www.hkllp.com/) in Austin, Texas, principally authored the brief and argued the case for the plaintiff. (PRWeb Sep 5, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/hormone-therapy-lawsuit/minnesota-supreme-court/prweb2837374.htm">http://www.prweb.com/releases/hormone-therapy-lawsuit/minnesota-supreme-court/prweb2837374.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/hormone-therapy-lawsuit/minnesota-supreme-court/prweb2837374.htm</guid>
</item>

<item>
    <title>Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose</title>
    <link>http://www.prweb.com/releases/2009/08/prweb2762414.htm</link>
    <description>
        <![CDATA[  <P>The law firm of Hissey Kientz, LLP is urging the manufacturers of the fentanyl or Duragesic pain patches (http://www.hkllp.com/duragesic-patch/) to address recurring problems with their products that could lead to a potentially fatal overdose. Because of its high potency, patients who receive too much of the medication in the pain patch are at an increased risk of a fentanyl overdose. Watson Pharmaceuticals recalled one lot of its fentanyl patches on August 7, 2009. The patches were recalled because a number of them have been leaking fentanyl gel. (PRWeb Aug 19, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/08/prweb2762414.htm">http://www.prweb.com/releases/2009/08/prweb2762414.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2009/08/prweb2762414.htm</guid>
</item>

<item>
    <title>Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website</title>
    <link>http://www.prweb.com/releases/herbal-fen-phen/ephedra/prweb2728914.htm</link>
    <description>
        <![CDATA[  <P>The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Herbal Fen Phen Lawyers (http://www.herbalfenphenlawyers.com/). Herbal Fen Phen products have been marketed to former patients as a &#8220;natural alternative&#8221; to Fen Phen, despite warnings from the FDA that herbal Fen Phen may be linked to serious side effects, including primary pulmonary hypertension (PPH), high blood pressure, heart attacks, strokes or death. (PRWeb Aug 8, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/herbal-fen-phen/ephedra/prweb2728914.htm">http://www.prweb.com/releases/herbal-fen-phen/ephedra/prweb2728914.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/herbal-fen-phen/ephedra/prweb2728914.htm</guid>
</item>

<item>
    <title>Reglan Adverse Events More Than Doubled from 2006 to 2008</title>
    <link>http://www.prweb.com/releases/2009/07/prweb2605904.htm</link>
    <description>
        <![CDATA[  <P>Recent data from the Food and Drug Administration&#8217;s Adverse Event Reporting System reveals that new cases of tardive dyskinesia (http://www.hkllp.com/reglan/signs-of-tardive-dyskinesia/) or other movement disorders reported by users of Reglan (or its generic version, metoclopramide) more than doubled between 2006 and 2008. In February 2009, the FDA forced the manufacturers of Reglan and metoclopramide (http://www.hkllp.com/reglan/) to add a black-box warning to their labels about the strong connection between tardive dyskinesia and the long-term use of Reglan. (PRWeb Jul 7, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/07/prweb2605904.htm">http://www.prweb.com/releases/2009/07/prweb2605904.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2009/07/prweb2605904.htm</guid>
</item>

<item>
    <title>Analysis of FDA Adverse Events Data Reveals at Least 106 Serious Conditions Reported Among Reglan Users</title>
    <link>http://www.prweb.com/releases/2009/05/prweb2400674.htm</link>
    <description>
        <![CDATA[  <P>An analysis of the Food and Drug Administration&#8217;s Adverse Event Reporting System has identified at least 106 cases of tardive dyskinesia or other movement disorders reported among users of Reglan (http://www.hkllp.com/reglan-metoclopramide/) or its generic version, metoclopramide. Tardive dyskinesia (http://www.hkllp.com/reglan-metoclopramide/signs-of-tardive-dyskinesia/) is a neurological disorder characterized by involuntary, repetitive movements of the extremities, including lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers. These symptoms are rarely reversible and there is no known treatment. (PRWeb May 8, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/05/prweb2400674.htm">http://www.prweb.com/releases/2009/05/prweb2400674.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2009/05/prweb2400674.htm</guid>
</item>

<item>
    <title>Supreme Court Ruling is a Victory for Consumers Injured by Dangerous Drugs, Says Hissey Kientz, LLP</title>
    <link>http://www.prweb.com/releases/2009/03/prweb2210564.htm</link>
    <description>
        <![CDATA[  <P>A ruling this week by the U.S. Supreme Court will protect the rights of consumers who are injured by dangerous drugs, according to Hissey Kientz, LLP (http://www.hkllp.com/). &#8220;The Supreme Court&#8217;s ruling this week is an important victory for plaintiffs who have been hurt by dangerous or defective drugs,&#8221; said attorney Robert Kientz. (PRWeb Mar 6, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/03/prweb2210564.htm">http://www.prweb.com/releases/2009/03/prweb2210564.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2009/03/prweb2210564.htm</guid>
</item>

<item>
    <title>Hissey Kientz, LLP Announces Its Support For A New Bill That Would Protect The Rights Of Victim Of Asbestos Exposure Who Have Developed Malignant Mesothelioma</title>
    <link>http://www.prweb.com/releases/2009/02/prweb2191164.htm</link>
    <description>
        <![CDATA[  <P>Hissey Kientz, LLP announces its support for a new bill that would protect the rights of victim of asbestos exposure who have developed malignant mesothelioma. &#8220;This is an important bill that would ensure that the legal rights of individuals in Texas who have developed mesothelioma after being exposed to asbestos are protected,&#8221; said attorney Robert Kientz. (PRWeb Feb 27, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/02/prweb2191164.htm">http://www.prweb.com/releases/2009/02/prweb2191164.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2009/02/prweb2191164.htm</guid>
</item>

<item>
    <title>Hissey Kientz, LLP Announces the Launch of Mesothelioma Lawyers Help Web Site</title>
    <link>http://www.prweb.com/releases/2009/02/prweb2134424.htm</link>
    <description>
        <![CDATA[  <P>The law firm of Hissey Kientz, LLP has announced the launch of its new website, Mesothelioma Lawyers Help (http://www.mesotheliomalawyershelp.com). Mesothelioma is a deadly form of cancer linked to exposure to asbestos. Thousands of workers and other individuals have developed mesothelioma after being exposed to asbestos in the workplace or by using products that contain asbestos. (PRWeb Feb 21, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/02/prweb2134424.htm">http://www.prweb.com/releases/2009/02/prweb2134424.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2009/02/prweb2134424.htm</guid>
</item>

<item>
    <title>Hissey Kientz, LLP Warns Duragesic Patch Users About Potential Health Risks of Fentanyl Overdose</title>
    <link>http://www.prweb.com/releases/2008/12/prweb1744344.htm</link>
    <description>
        <![CDATA[  <P>Hissey Kientz, LLP wishes to alert patients of the serious and potentially fatal health risks they may face from using the Duragesic (fentanyl) pain patch. Patients who are directly exposed to the gel inside the patch, or who received an excessive fentanyl dose because of other factors, may develop respiratory depression or other serious and potentially fatal side effects. (PRWeb Dec 13, 2008)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/12/prweb1744344.htm">http://www.prweb.com/releases/2008/12/prweb1744344.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2008/12/prweb1744344.htm</guid>
</item>

<item>
    <title>Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site</title>
    <link>http://www.prweb.com/releases/2008/09/prweb1370794.htm</link>
    <description>
        <![CDATA[  <P>The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help (http://www.digitekrecallhelp.com). Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. The drug&#039;s manufacturer issued a nationwide Digitek recall  after receiving several reports of injuries or illnesses among patients. (PRWeb Sep 23, 2008)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/09/prweb1370794.htm">http://www.prweb.com/releases/2008/09/prweb1370794.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2008/09/prweb1370794.htm</guid>
</item>

<item>
    <title>Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity</title>
    <link>http://www.prweb.com/releases/2008/08/prweb1190604.htm</link>
    <description>
        <![CDATA[  <P>Hissey Kientz, LLP is concerned that despite a recent recall notice for the heart drug Digitek, the drug&#8217;s manufacturer has failed to provide any additional information on how long the heart medication was being improperly manufactured. According to a press release issued by the manufacturer, some Digitek tablets may have been manufactured at double their normal strength, meaning that patients could receive a double dose of the drug, leading to an overdose. A Digitek overdose could lead to severe side effects, including heart attack, stroke or death. (PRWeb Aug 16, 2008)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/08/prweb1190604.htm">http://www.prweb.com/releases/2008/08/prweb1190604.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2008/08/prweb1190604.htm</guid>
</item>

<item>
    <title>Thousands Still Not Warned of Hepatitis Exposure at Las Vegas Clinics</title>
    <link>http://www.prweb.com/releases/2008/05/prweb942214.htm</link>
    <description>
        <![CDATA[  <P>Two Las Vegas clinics are linked to an outbreak of hepatitis C and HIV. The Nevada  Health District sent more than 40,000 &quot;Dear Patient&quot; letters to those treated after March 2004 . Patients treated before March 2004 have not been warned that they are at risk of infection of these contagious diseases. (PRWeb May 22, 2008)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb942214.htm">http://www.prweb.com/releases/2008/05/prweb942214.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2008/05/prweb942214.htm</guid>
</item>

<item>
    <title>Drug Companies Seek to Invoke Shield Law of Preemption</title>
    <link>http://www.prweb.com/releases/2008/05/prweb945174.htm</link>
    <description>
        <![CDATA[  <P>An anticipated US  Supreme Court ruling may prevent victims injured by the Ortho Evra patch and other harmful drugs from having their day in court, according to Hissey Kientz, LLP. (PRWeb May 15, 2008)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb945174.htm">http://www.prweb.com/releases/2008/05/prweb945174.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2008/05/prweb945174.htm</guid>
</item>

</channel>
</rss>